24-Hour Ambulatory Blood Pressure Monitoring in Male Children Receiving Stimulant Therapy

Abstract

Spanish

French

OBJECTIVE:

To determine whether cardiac indices are altered as assessed by 24-hour ambulatory blood pressure monitoring (ABPM) in male children receiving either chronic methylphenidate or dextroamphetamine/levoamphetamine (Adderall) therapy.

METHODS:

Boys 7–11 years old who were receiving methylphenidate or Adderall for a minimum of 2 months were asked to participate. Subjects wore ambulatory blood pressure monitors for 24-hour periods both off and on stimulant therapy.

RESULTS:

Subjects (n = 17; 8 methylphenidate, 9 Adderall) were well matched. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate differed between off and on stimulant therapy (p < 0.05). DBP load calculated from ABPM reference data was increased significantly (9.0% ± 5.6% on and 4.8% ± 4.5% off therapy; p < 0.05) while subjects were taking Adderall. There was a trend toward a greater elevation in blood pressure load during awake hours and a more pronounced decrease during the asleep hours for periods on compared with off-stimulant therapy. This trend resulted in significant (p < 0.05) nocturnal dipping on-stimulant phases compared with off-stimulant therapy for both SBP and DBP (Adderall) and SBP (methylphenidate). Two subjects (1 Adderall, 1 methylphenidate) met the criteria to be considered hypertensive based both on mean awake and 24-hour blood pressure load assessments during their on-treatment period. One additional subject receiving Adderall therapy met the criteria to be considered hypertensive based on blood pressure load criteria while off therapy only. Positive correlation coefficients (p < 0.05) were found when comparing stimulant dose (mg/kg) with the percent change of mean SBP, DBP, and heart rate between off and on therapy (r = 0.56, 0.61, and 0.58, respectively).

CONCLUSIONS:

These preliminary data suggest that blood pressure and heart rate appear to be altered in male patients while receiving stimulant therapy for attention-deficit hyperactivity disorder. Blood pressure and heart rate screening and monitoring during stimulant therapy to determine whether alterations become clinically significant is encouraged.

Keywords

ambulatory blood pressure monitoring attention-deficit hyperactivity disorder blood pressure heart rate stimulant therapy

Get full access to this article

View all access options for this article.

References

Goldman

Genel

Bezman

Slanetz

. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279: 1100–7.

Brown

Freeman

Perrin

Stein

Amler

Feldman

Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107(3):e43. Available from: URL: http://www.pediatrics.org/cgi/content/full/107/3/e43.

Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994: 78–85.

Zametkin

Ernst

. Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med 1999;340: 40–6.

Elia

Ambrosini

Rapoport

. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 1999;340: 780–7.

Bennett

Brown

Craver

Anderson

. Stimulant medication for the child with attention-deficit/hyperactivity disorder. Pediatr Clin North Am 1999;46: 929–44.

Hoffman

. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonist. In: Hardman

Limbird

Gilman

, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001: 215–68.

Volkow

Wang

Gatley

Fowler

Ding

Logan

Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 1996;123: 26–33.

Goldstein

Nurnberger

Simmons

Gershon

Polinsky

Keiser

. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. Life Sci 1983;32: 1057–63.

10.

Martin

Sloan

Sapira

Jasinski

. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Toxicol 1971;12: 245–58.

11.

Aman

Werry

. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action. Psychopharmacologia (Berl) 1975;43: 163–8.

12.

Ballard

Boileau

Sleator

Massey

Sprague

. Cardiovascular response of hyperactive children to methylphenidate. JAMA 1976;236: 2870–4.

13.

Brown

Sexson

. Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disorder adolescents. J Adolesc Health Care 1989;10: 179–83.

14.

Brown

Sexson

. A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects. Clin Pediatr (Phila) 1988;27: 74–81.

15.

Greenberg

Yellin

. Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate. Am J Psychiatry 1975;12: 1325–6.

16.

Brown

Wynne

Slimmer

. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 1984;45: 473–6.

17.

Pataki

Carlson

Kelly

Rapport

Biancaniello

. Side effects of methylphenidate and desipramine alone and in combination in children. J Am Acad Child Adolesc Psychiatry 1993;32: 1065–72.

18.

Stowe

Gardner

. Hypertension associated with Adderall use in a pediatric patient with ADHD. J Pediatr Pharmacol Ther 2001;6: 347–50.

19.

Belsha

Wells

Rice

Neaville

Berry

. Accuracy of the SpaceLabs 90207 ambulatory blood pressure monitor in children and adolescents. Blood Pressure Monitor 1996;1: 127–33.

20.

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents [see comments]. Pediatrics 1996;98(4 pt 1):649–58.

21.

Soergel

Kirschstein

Busch

Danne

Gellermann

Holl

Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects. J Pediatr 1997;130: 178–84.

22.

Sorof

Poffenbarger

Portman

. Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis 2000;35: 681–6.

23.

Verdecchia

Schillaci

Guerrieri

Gatteschi

Benemio

Boldrini

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81: 528–36.

24.

Tirosh

Sadeh

Munvez

Lavie

. Effects of methylphenidate on sleep in children with attention-deficit hyperactivity disorder: An activity monitor study. Am J Dis Child 1993;147: 1313–5.

25.

Busby

Pivik

. Auditory arousal thresholds during sleep in hyperkinetic children. Sleep 1985;8: 332–41.

26.

Leary

Donnan

MacDonald

Murphy

. Physical activity level is an independent predictor of the diurnal variation in blood pressure. J Hypertens 2000;18: 405–10.

27.

Suzuki

Guilleminault

Otsuka

Shiomi

. Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep 1996;19: 382–7.

28.

Sorof

Mielke

Portman

. Ambulatory blood pressure monitoring (ABPM) data are correlated with LV mass index (LVMI) and predictive of LV hypertrophy (LVH) in children with hypertension (HTN) (abstract). Am J Hypertens 2000;13:39A.

29.

Belsha

Wells

McNiece

Seib

Plummer

Berry

. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998;11: 410–7.

30.

Kapuka

Trieber

Davis

Harshfield

Cook

Mensah

. Hemodynamic function at rest, during acute stress, and in the field: Predictors of cardiac structure and function 2 years later in youth. Hypertension 1999;34: 1026–31.